health
Abbott Study Links CGM Use to Lower Mortality in Type 2 Diabetes
Abbott's Libre CGM use was associated with nearly 50% fewer acute Type 2 diabetes-related hospitalizations in one study.
Abbott presented data at this week’s European Association for the Study of Diabetes (EASD) meeting showing use of continuous glucose monitoring (CGM), including its Libre technology, was linked to lower risks of death and cardiovascular complications... [1762 chars]
Read Full ArticleShare this story
Up next
Related Stories
Childhood Obesity: How Can It Be Avoided?
Newswise
WHO Reports Latest Global Trends in Cholera, Meningitis and Plague
The Indian Practitioner
Can Infections Cause Cancer? Lancet Study Links 1 In 8 Cancer Cases To Viruses
NDTV
India has PET-CT machines-So why are cancer patients still waiting for reports?
theweek.in
Decaf helps the memory, and caffeine eases anxiety: Coffee study
ThePrint